FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Hybrid Pharma | 079665742 | 26436-5152 | 26436-5152-1 | Progesterone | 150 mg | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5248 | 26436-5248-1 | Progesterone | 125 mg | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5363 | 26436-5363-1 | Progesterone | 175 mg | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5130 | 26436-5130-5 | "phenylephrine Hydrochloride, (+/-)-" | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-0163 | 26436-0163-5 | Testosterone | 100 mg/1 g | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5180 | 26436-5180-1 | Testosterone | 100 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5074 | 26436-5074-1 | Testosterone Cypionate | 200 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5319 | 26436-5319-1 | Testosterone Cypionate; Testosterone Enanthate | 180 mg/1 mL; 20 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5345 | 26436-5345-1 | Testosterone Cypionate; Testosterone Propionate | 180 mg/1 mL; 20 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5092 | 26436-5092-1 | Testosterone Enanthate | 200 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5093 | 26436-5093-1 | Testosterone Propionate | 100 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5130 | 26436-5130-1 | "phenylephrine Hydrochloride, (+/-)-" | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5030 | 26436-5030-3 | Cyanocobalamin | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5009 | 26436-5009-3 | Cyanocobalamin | 1000 ug/1 mL | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5150 | 26436-5150-1 | Doxycycline Hyclate | .25 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5342 | 26436-5342-1 | Estriol | 2 mg | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5343 | 26436-5343-1 | Estriol | 2 mg | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5364 | 26436-5364-3 | Estriol; Testosterone; Estradiol | 1 mg/1 g; 1.5 mg/1 g; 1 mg/1 g | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5037 | 26436-5037-1 | Alprostadil; Papaverine Hydrobromide; Phentolamine Mesylate | 10 ug/1 mL; 30 mg/1 mL; 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5037 | 26436-5037-5 | Alprostadil; Papaverine Hydrobromide; Phentolamine Mesylate | 10 ug/1 mL; 30 mg/1 mL; 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Infusion Options Inc. | 147999205 | Ampicillin Sodium | 20 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Ampicillin Sodium | 20 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Ampicillin Sodium; Sulbactam Sodium | 10 mg; 5 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Ampicillin Sodium; Sulbactam Sodium | 20 mg; 10 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Meropenem | 20 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Azithromycin Monohydrate | 2 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Aztreonam | 40 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Aztreonam | 20 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Micafungin Sodium | 1 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Nafcillin Sodium | 20 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Oxytocin | .06 U | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Oxytocin | .04 U | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Oxytocin | .06 U | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Oxytocin | .02 U | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Penicillin G Potassium | 20000 U | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Penicillin G Potassium | 25000 U | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Piperacillin Sodium; Tazobactam Sodium | 40 mg; 5 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Piperacillin Sodium; Tazobactam Sodium | 40 mg; 5 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Polymyxin B Sulfate | 2000 U | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Tazobactam Sodium; Piperacillin Sodium | 7.5 mg; 60 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Tranexamic Acid | 10 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Vancomycin Hydrochloride | 4 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Vancomycin Hydrochloride | 5 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Vancomycin Hydrochloride | 3 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Vancomycin Hydrochloride | 4 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Cefazolin Sodium | 200 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Cefazolin Sodium | 20 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Cefepime Hydrochloride | 20 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Cefepime Hydrochloride | 40 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Infusion Options Inc. | 147999205 | Ceftriaxone Sodium | 20 mg | 2019-1 | source_no_ndc | 2026-11-14 |